Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BRCA1/2 Mutation Types Do Not Affect Prognosis in Ovarian Cancer Patients.
Liontos M, Zografos E, Zoumpourlis P, Andrikopoulou A, Svarna A, Fiste O, Kunadis E, Papatheodoridi AM, Kaparelou M, Koutsoukos K, Thomakos N, Haidopoulos D, Rodolakis A, Dimopoulos MA, Zagouri F. Liontos M, et al. Among authors: kaparelou m. Curr Oncol. 2021 Nov 3;28(6):4446-4456. doi: 10.3390/curroncol28060377. Curr Oncol. 2021. PMID: 34898566 Free PMC article.
Management of uterine sarcomas and prognostic indicators: real world data from a single-institution.
Kyriazoglou A, Liontos M, Ziogas DC, Zagouri F, Koutsoukos K, Tsironis G, Tsiara A, Kaparelou M, Zakopoulou R, Thomakos N, Haidopoulos D, Papaspyrou I, Rodolakis A, Bamias A, Dimopoulos MA. Kyriazoglou A, et al. Among authors: kaparelou m. BMC Cancer. 2018 Dec 13;18(1):1247. doi: 10.1186/s12885-018-5156-1. BMC Cancer. 2018. PMID: 30541504 Free PMC article.
Lymphocytic infiltration and Chemotherapy Response Score as prognostic markers in ovarian cancer patients treated with Neoadjuvant chemotherapy.
Liontos M, Sotiropoulou M, Kaparelou M, Tzannis K, Tsironis G, Kyriazoglou A, Tsiara A, Zakopoulou R, Koutsoukos K, Zagouri F, Thomakos N, Haidopoulos D, Rodolakis A, Dimopoulos MA, Bamias A. Liontos M, et al. Among authors: kaparelou m. Gynecol Oncol. 2020 Jun;157(3):599-605. doi: 10.1016/j.ygyno.2020.03.008. Epub 2020 Mar 12. Gynecol Oncol. 2020. PMID: 32173048
Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19.
Liontos M, Kaparelou M, Karofylakis E, Kavatha D, Mentis A, Zagouri F, Terpos E, Dimopoulos MA. Liontos M, et al. Among authors: kaparelou m. Gynecol Oncol Rep. 2020 Jul 30;33:100615. doi: 10.1016/j.gore.2020.100615. eCollection 2020 Aug. Gynecol Oncol Rep. 2020. PMID: 32766415 Free PMC article.
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors.
Zagouri F, Terpos E, Fiste O, Liontos M, Briasoulis A, Katsiana I, Skafida E, Markellos C, Kunadis E, Andrikopoulou A, Kaparelou M, Koutsoukos K, Gavriatopoulou M, Kastritis E, Trougakos IP, Dimopoulos MA. Zagouri F, et al. Among authors: kaparelou m. Breast. 2021 Dec;60:58-61. doi: 10.1016/j.breast.2021.08.017. Epub 2021 Aug 28. Breast. 2021. PMID: 34481366 Free PMC article.
Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients.
Liontos M, Terpos E, Kunadis E, Zagouri F, Briasoulis A, Skafida E, Fiste O, Markellos C, Andrikopoulou A, Gumeni S, Kaparelou M, Koutsoukos K, Gavriatopoulou M, Kastritis E, Trougakos IP, Dimopoulos MA. Liontos M, et al. Among authors: kaparelou m. Prostate Cancer Prostatic Dis. 2022 Mar;25(1):117-118. doi: 10.1038/s41391-021-00455-9. Epub 2021 Oct 9. Prostate Cancer Prostatic Dis. 2022. PMID: 34628475 Free PMC article.
34 results